Thu, March 10, 2022

Kemp Dolliver Initiated (VRCA) at Strong Buy and Held Target at $20 on, Mar 10th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-20-on-mar-10th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Kemp Dolliver of Brookline Capital, Initiated "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy and Held Target at $20 on, Mar 10th, 2022.

Kemp has made no other calls on VRCA in the last 4 months.



There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Kemp's Rating of Hold.



This is the rating of the analyst that currently disagrees with Kemp


  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $18 on, Thursday, March 3rd, 2022